237 related articles for article (PubMed ID: 6172706)
41. Inosiplex: antiviral, immunomodulator, or neither?
Lancet; 1982 May; 1(8280):1052-4. PubMed ID: 6176822
[No Abstract] [Full Text] [Related]
42. [Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing panencephalitis].
Sobczyk W; Piłkowska E; Iwińska-Buksowicz B; Jakubowska T
Neurol Neurochir Pol; 1997; 31(6):1147-56. PubMed ID: 9591301
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of a patient with SSPE].
Goetz O; Peller P
Monatsschr Kinderheilkd (1902); 1980 May; 128(5):246-7. PubMed ID: 6158679
[No Abstract] [Full Text] [Related]
44. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
[TBL] [Abstract][Full Text] [Related]
45. Bilateral optic neuritis--the only ocular finding in a case of subacute sclerosing panencephalitis.
Ozer PA; Ozkan M; Sekeroglu HT; Kadayifcilar S; Yuksel D; Aksoy A
Ocul Immunol Inflamm; 2014 Feb; 22(1):82-5. PubMed ID: 24063631
[TBL] [Abstract][Full Text] [Related]
46. [Antiviral treatment of subacute sclerosing panencephalitis].
Sobczyk W; Kulczycki J
Neurol Neurochir Pol; 1981; 15(2):143-8. PubMed ID: 6167886
[TBL] [Abstract][Full Text] [Related]
47. SSPE and interferon.
Philippart M
Brain Dev; 1994; 16(2):168. PubMed ID: 7519415
[No Abstract] [Full Text] [Related]
48. Preliminary results for treatments in subacute sclerosing panencephalitis have problems?
Anlar B
J Child Neurol; 2004 Jun; 19(6):463; author reply 463-4. PubMed ID: 15446398
[No Abstract] [Full Text] [Related]
49. Medical registers as historical controls: analysis of an open clinical trial of inosiplex in subacute sclerosing panencephalitis.
Hoehler FK; Mantel N; Gehan E; Kahana E; Alter M
Stat Med; 1984; 3(3):225-37. PubMed ID: 6207580
[TBL] [Abstract][Full Text] [Related]
50. Measles vaccine versus inosiplex.
Noah ND; Miller CL
Lancet; 1982 Jun; 1(8286):1420. PubMed ID: 6177982
[No Abstract] [Full Text] [Related]
51. [Changes of cognitive and emotional processes during immunostimulatory treatment in subacute sclerosing panencephalitis].
Jakubowska T; Luczywek E; Sobczyk W; Piłkowska E
Neurol Neurochir Pol; 1993; 27(1):45-53. PubMed ID: 7684827
[TBL] [Abstract][Full Text] [Related]
52. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
Noetzel MJ; Dodson WE
Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
[TBL] [Abstract][Full Text] [Related]
53. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
Anlar B; Guven A; Köse G; Okur H; Kose O; Aydin OF; Kabakus N; Altunbasak S; Herguner O; Sonmez M; Serdaroglu A
J Neuroimmunol; 2005 Jun; 163(1-2):195-8. PubMed ID: 15885323
[TBL] [Abstract][Full Text] [Related]
54. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
55. SSPE, measles virus, and the matrix protein: report of a case with unusual immunochemical findings.
Mandelbaum DE; Hall WW; Paneth N; Wolff RR; DeVivo DC
Ann Neurol; 1981 Oct; 10(4):351-4. PubMed ID: 6172078
[TBL] [Abstract][Full Text] [Related]
56. Adult-onset subacute sclerosing panencephalitis first seen as craniocervical myoclonus.
Vela L; Garcia-Merino A; Escamilla C
Mov Disord; 1997 May; 12(3):462-4. PubMed ID: 9159751
[No Abstract] [Full Text] [Related]
57. Subacute sclerosing panencephalitis masquerading as toxoplasmosis chorioretinitis.
Chawla A; Jain S
Can J Ophthalmol; 2012 Apr; 47(2):e1-2. PubMed ID: 22560432
[No Abstract] [Full Text] [Related]
58. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
Anlar B; Yalaz K; Köse G; Saygi S
J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
[TBL] [Abstract][Full Text] [Related]
59. [Propionibacterium granulosum KP-45 in the treatment of subacute sclerosing panencephalitis].
Sobczyk W; Kulczycki J; Iwińska B; Vainiene M; Plachcińska J; Szmigielskí S; Pulverer G; Jeliaszewicź J
Psychiatr Neurol Med Psychol (Leipz); 1989 Jun; 41(6):344-51. PubMed ID: 2475877
[TBL] [Abstract][Full Text] [Related]
60. Long-term survival of a case of subacute sclerosing panencephalitis.
Barraclough CR
J Neurol Neurosurg Psychiatry; 1983 May; 46(5):457-8. PubMed ID: 6086104
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
